| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 39.0932 | 4 |
| GSM780708 | Untreated after 4 days (C2_1) | 45.0768 | 27 |
| GSM780709 | Untreated after 4 days (C3_1) | 46.3265 | 34 |
| GSM780719 | Untreated after 4 days (C1_2) | 41.4099 | 11 |
| GSM780720 | Untreated after 4 days (C2_2) | 43.3863 | 19 |
| GSM780721 | Untreated after 4 days (C3_2) | 37.3172 | 2 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 42.9545 | 17 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 39.0532 | 4 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 45.2018 | 28 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 42.4057 | 15 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 38.4959 | 3 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 49.6712 | 47 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 39.9159 | 6 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 44.5777 | 25 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 37.597 | 2 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 39.744 | 6 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 37.8576 | 2 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 40.9941 | 9 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 44.497 | 25 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 39.9069 | 6 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 41.4508 | 11 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 40.9091 | 9 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 40.2035 | 7 |